Author response: The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis
- Resource Type
- Source
- Subject
Drug Oral treatment medicine.medical_specialty 010405 organic chemistry business.industry media_common.quotation_subject medicine.disease 01 natural sciences Dermatology 0104 chemical sciences 010404 medicinal & biomolecular chemistry Visceral leishmaniasis Medicine Delamanid business Anti tubercular medicine.drug media_common - Language